Introduction
The treatment of chronic non-healing wounds is challenging. When traditional wound care methods fail, alternative treatments are needed to prevent chronic ulcer complications, such as amputation. CO 2 laser can be a valid alternative to traditional surgery because of its versatility (possibility of non-vital tissue vaporization, cutting, hemostasis, controlling local infection [1, 2] in the treatment of skin ulcers, as described in several case reports [2] [3] [4] [5] [6] [7] [8] [9] and in a randomized clinical trial on decubitus ulcers [1] .
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The local application of platelet-rich plasma (PRP) has been proposed as a therapeutic tool for accelerating healing in foot ulcers, including those in patients with diabetes [10] . PRP contains (and releases through degranulation) several different growth factors and other cytokines and it enhances healing in diabetic patients with lower limb ulcers.
Aim of the present pilot, proof-of-concept study is the assessment of the therapeutic potential of CO 2 laser treatment, either alone or combined with PRP, in the treatment of diabetic foot ulcers with exposed bone.
Methods
We performed a pilot, uncontrolled 3-month observational study on 14 type two diabetic patients and neuro-ischemic ulcers of lower limbs with exposed bone (with or without radiologic signs of osteomyelitis). Patients were excluded if they had a critical lower limb ischemia needing an immediate revascularization (ankle-brachial index >0.5), whereas those with non-critical ischemia were included. Patients fulfilling inclusion criteria, and who had been all entered in a surgical waiting list for amputations, were included in this study. After washing the ulcers, a DEKA SmartXide 2 C80 (DEKA, Florence, Italy) CO 2 -laser was used for producing discontinuities on periosteum of exposed bone (nine discontinuities for each cm 2 of exposed bone), by repeatedly directing the focused laser beam on the bone until bleeding. The laser beam (wavelength 10,600 nm) was used in Ultrapulsed mode, with repeat mode of emission (0.05 s on/0.70 s off), with 80 W power, providing trains of single pulses with energy of 4 J each. After bleeding, an adequatesized Promogran® (Systagenix) dressing was placed on the bone surface for 5-7 days. The procedure was repeated up to 6 times, at a distance of one week, and patients evaluated every week until the end of the study (3 months).
In the last 5 of the 14 patients, the treatment described above was associated with PRP. After bleeding, PRP was applied on an adequate-sized Hyalofil® (Fidia farmaceutici S.p.A) dressing placed on the bone surface. Autologous PRP was obtained from whole blood through the centrifugation of a test tube or a blood bag (Crossover 2 REGEN Kit ATHENA; Florence). The procedure was repeated up to 4 times, at a distance of 1 week.
Ulcers were classified according to University of Texas score [11] . A photograph of the wound was recorded at each visit and ulcer area, percentage of granulation, fibrin, necrosis, and bone covering wound surface were calculated using MOWA (Mobile Wound Analyzer version 1.7 for iPhone/iPad, http://www.healthpath.it) [12] . Changes in size, percentage of bone exposed, granulation, necrotic, and fibrotic tissue were assessed weekly for 3 months, or until complete healing, defined as full epithelialization of the wound with the absence of drainage. Local medications were performed following the Practical Guidelines on the management of Foot Ulceration based upon the International Consensus on the Diabetic Foot [13] . All patients received systemic antibiotic therapy, chosen on the basis of antibiogram. Therapeutic shoes were prescribed to all patients for pressure relief.
Results
The main characteristics of the 14 patients enrolled are summarized in Table 1 .
CO 2 laser alone
Of the nine patients treated with CO 2 laser alone, four healed within 3 months, and one more patient developed granulation tissue covering entirely bone surface. Out of the four patients who did not heal, one underwent minor amputation. Variations in wound area covered by bone and granulation tissue at each visit is reported in Fig. 1 . The description of a case treated with CO 2 -laser alone is reported in supplementary materials. CO 2 laser and PRP Among the five patients treated with a combination of CO 2 laser and PRP, two healed within 3 months, and two more patients developed granulation tissue covering entirely bone surface; the fifth patient did not show any improvement and underwent amputation. The cases are briefly described below.
Case 1 C.B., a 70-year-old man, had an ulcer (total area of 8.7 cm 2 ; Texas grade 3D) in the lower pretibial region. No dry necrolytic tissue was present, and granulation tissue was detectable near the exposed bone. Cultural examination of wound fluid identified Staphylococcus aureus and Escherichia coli. The above described procedure was applied three times. Improvement was noticeable after 7 days, with the presence of granulation tissue and reduction of wound area. Healing was complete within 5 weeks from the beginning of treatment.
Case 2 G.G., a woman aged 78 years, had an ulcer (total area of 4.3 cm 2 ; Texas grade 3D) on the first toe of the left foot. Granulation tissue was detectable only in the peripheral area of the ulcer. Cultural examination of wound fluid identified Pseudomonas aeruginosa and Streptococcus agalactiae. The above described procedure was applied six times with the presence of granulation tissue and reduction of wound area after 4 weeks. At 3 months, ulcer did not completely heal, with an area of 2.2 cm 2 .
Case 3 M.P., a 77-year-old man, had an ulcer (total area of 24.2 cm 2 ; Texas grade 3 C) in plantar region of the right foot. Granulation tissue was absent and the ulcer was entirely covered by necrolytic dry tissue. The above described procedure was applied three times with the presence of granulation tissue after 2 weeks. Healing was complete within 4 weeks from the beginning of treatment.
Case 4 P.C., a woman aged 73 years, had an ulcer (total area of 4.3 cm 2 ; Texas grade 3D) on the first toe of the left foot. Granulation tissue was detectable only in the peripheral area of the ulcer (about 25%). Cultural examination of wound fluid identified E. faecalis. The above described procedure was applied six times with the presence of granulation tissue and reduction of wound area after 4 weeks. At 3 months, ulcer did not completely heal, with an area of 1.2 cm 2 , but granulation tissue covered entirely the ulcer surface at week 8.
Case 5 F.B., a 71-year-old man, had an ulcer (total area of 14.1 cm 2 ; Texas grade 3D) in malleolar region of the left foot. Granulation tissue was present (about 40%) near the exposed bone. Cultural examination of wound fluid identified E. faecalis and A. Baumanii. The above described procedure was applied six times with the presence of granulation tissue after 8 weeks partially covering the bone surface. Healing was not possible and the patient underwent major amputation.
Conclusions
Diabetic foot ulcers with exposure of bone surface are usually at high risk for amputation. In fact, bone exposure is often complicated by osteomyelitis, which is difficult to eradicate with antibiotic therapy, in particular when ischemia is present. In addition, the formation of granulation tissue in ulcers with a relevant exposure of bone is problematic, increasing the risk of complications and delay in healing process [14] .
This new technique, using a CO 2 laser beam of adequate wavelength and intensity, can be used to produce The present pilot experience represents a novelty in this field showing a possible use of CO 2 laser in the treatment of diabetic foot ulcers. However, it should be recognized that the scarce number of patients included in this preliminary study and the lack of a control group prevent a full evaluation of the new procedure. In fact, the efficacy of this procedure should be verified through a properly sized and specifically designed randomized controlled trial, although randomization may not guarantee equipoise of treatment in patients otherwise candidate to amputation. In addition, the small number of patients treated prevents the exploration of possible moderators of response, such as leg perfusion.
On the other hand, the results of the present series of uncontrolled observations are encouraging, with a 43% healing rate within 3 months. It should be recognized that all patients enrolled would have probably undergone amputation, if this new technique had not been applied.
The combination of CO 2 laser treatment with PRP has a theoretical rational, since PRP is known to amplify the process of regeneration, stimulating the growth of circulating pluripotent stem cells, such as those with are made available through discontinuities in periosteum. The small series of patients receiving combined treatment had, on average, a satisfactory clinical result; further observations, and a formal randomized trial, are needed to gather information on this approach. In addition, a specific trial should be performed in order to verify the efficacy of PRP as addon therapy in patients treated with this new technique.
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